Cointime

bioSyntagma

company

About

A precision medicine company with novel technology enabling advanced diagnostics and biomarker discovery

  • 1 - 10

Highlights

Total Funding Amount
$1.30M
Funding Rounds
3
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$196K
Industries
Biotechnology,Life Science
Founded date
Apr 2, 2015
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.30M
bioSyntagma has raised a total of $1.30M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 19, 2018 Grant $196K 1 — — Detail
Feb 6, 2018 Grant $892.08K 1 National Science Foundation — Detail
Jan 1, 2017 Grant $214K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
bioSyntagma is funded by 2 investors. National Science Foundation and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท